Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose (Q61819220)
Jump to navigation
Jump to search
scientific article published on 01 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose |
scientific article published on 01 October 2007 |
Statements
Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose (English)
Eva Obermueller
Susan Hoare
Kim Edmonds
David Chao
Kate Hall
Chooi Lee
Eleni Timotheadou
Kellie Charles
Roger Ahern
Tim Eisen
Robert Corringham
Mark DeWitte
Martin Gore
Michelle L Harrison
Nick R Maisey
Ningfeng F Li
1 October 2007